Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
09/2011
09/20/2011US8022065 Purine derivatives as kinase inhibitors
09/20/2011CA2687035C Amino-heterocyclic compounds
09/20/2011CA2516934C Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives
09/20/2011CA2510534C Compositions useful as inhibitors of protein kinases
09/20/2011CA2467774C Solubilized topoisomerase poisons
09/20/2011CA2439415C Cathepsin cysteine protease inhibitors
09/15/2011WO2011112766A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease
09/15/2011WO2011112731A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease
09/15/2011WO2011112689A2 Saltz of an indazolylpyrrolotriazine
09/15/2011WO2011112596A2 Method of making a cyclic guanidine from a guanidinium salt and a weak acid and coating compositions containing same
09/15/2011WO2011111817A1 Benzazepine compound
09/15/2011WO2011110859A1 Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd
09/15/2011WO2011110858A1 Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd
09/15/2011WO2011110545A1 Imidazo [1, 2 -a] pyrazine derivatives and their use for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases
09/15/2011WO2011077099A3 Methods for the purification of cucurbituril
09/15/2011WO2011031554A3 Heterocyclic compounds as janus kinase inhibitors
09/15/2011US20110224436 Regioselective reduction of fused pyrrolocarbazoles-5,7-diones
09/15/2011US20110224426 Process for the preparation of carbapenem compounds
09/15/2011US20110224328 Method of making a cyclic guanidine from a guanidinium salt and a weak acid and coating compositions containing the same
09/15/2011US20110224222 Cdk inhibitor for the treatment of mesothelioma
09/15/2011US20110224220 Substituted tricyclic derivatives
09/15/2011US20110224214 Process for preparing polymorph
09/15/2011US20110224199 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues
09/15/2011US20110224195 Heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
09/15/2011US20110224190 Piperidin-4-yl azetidine derivatives as jak1 inhibitors
09/15/2011US20110224188 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-alpha]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
09/15/2011US20110224187 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof
09/15/2011US20110224185 Compounds and compositions as modulators of gpr119 activity
09/15/2011CA2792918A1 Benzazepine compound
09/15/2011CA2792726A1 Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd
09/15/2011CA2792725A1 Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd
09/15/2011CA2791417A1 Heterocyclic inhibitors of histamine receptors for the treatment of disease
09/15/2011CA2790571A1 Imidazo [1, 2 -a] pyrazine derivatives and their use for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases
09/14/2011EP2364316A1 6, 7 -dihydro- 5h- pyrrolo [3, 4-d¨pyrimidin-4-yl]-quinolin-3 -ylamine compounds useful as FAAH modulators and uses thereof
09/14/2011EP2364315A1 Process for preparing polymorph of 7-chloro-n, n,5-trimethyl-4-oxo-3-phenyl-3,5-dihydr0-4h-pyridazin0[4,5-b]indole-1-acetamide
09/14/2011EP2364314A1 Modulators of toll-like receptors
09/14/2011EP2364313A1 Aza-benzimidazolone chymase inhibitors
09/14/2011EP2364312A2 Preparation of crystalline palonosetron hydrochloride
09/14/2011EP2364301A1 Enantiomerically enriched aryloazol- 2 -yl cyanoethylamino paraciticidal compounds
09/14/2011EP2145231B1 Photoactivable nitrogen bases
09/14/2011EP2139892B1 Substituted pyrimidodiazepines useful as plk1 inhibitors
09/14/2011EP1948663B1 Pyrazolo-pyrimidines as casein kinase ii (ck2) modulators
09/14/2011EP1948242B1 Cytotoxic compounds
09/14/2011EP1912997B1 Macrocyclic inhibitors of hepatitis c virus
09/14/2011EP1896421B1 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
09/14/2011EP1727820B1 Amine derivatives with tyrosinkinase inhibiting activity
09/14/2011EP1689387B1 Bicyclic inhibitors of mek and methods of synthesis thereof
09/14/2011EP1644344B1 Method of preparing cis-8b-methyldecahydro-2a,4a,6a,8a-tetraazacyclopenta [fg]acenaphthylene, cis-decahydro-2a,4a,6a,8a-tetraazacyclopenta [fg]acenaphthylene, cyclene and functionalised cyclenes
09/14/2011EP1446401B1 C5-modified indazolylpyrrolotriazines
09/14/2011CN1950373B Processes of preparing glycolurils and cucurbiturils using microwave
09/14/2011CN1918173B Novel indeno[2,1a]indenes and isoindol[2,1-a]indoles
09/14/2011CN102186856A Pyrrolopyrimidine compounds as cdk inhibitors
09/14/2011CN102186855A Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseases
09/14/2011CN102186854A Process for preparing polymorph of 7-chloro-n, n,5-trimethyl-4-oxo-3-phenyl-3,5-dihydr0-4h-pyridazin0[4,5-b]indole-1-acetamide
09/14/2011CN102186853A Alpha helix mimetics in the treatment of cancer
09/14/2011CN102186852A 2-alkyl-6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-ib]-pyridazine derivatives, preparation thereof, and therapeutic application thereof
09/14/2011CN102183647A Kit and method for detecting hepatitis B virus surface antigen (HBsAg)
09/14/2011CN102180884A Preparation and application of one-class meso-position-tetra (phenyl-1,3-butadiyne) porphyrin-zn coordination complex derivative
09/14/2011CN102180883A Substituted porphyrin gold (III) compounds with anticancer activity and preparation method thereof
09/14/2011CN102180882A Water-soluble porphyrin iron
09/14/2011CN102180881A Preparation method for 3,8,13-triiodo-5,10,15-trialkyl tripolyindole
09/14/2011CN102180880A Method for synthesizing bromophenyl pyrazolo[3,4-d]pyrimidine derivative
09/14/2011CN102180879A Polycrystalline type alpha acetic acid solvate of hypnotic
09/14/2011CN102180838A Aromatic diamine containing imidazolyl and preparation method thereof
09/14/2011CN102180828A Chiral indolinone spiropentacyclic skeleton compounds and asymmetric synthesis thereof
09/14/2011CN101671341B Preparation method of iron chlorophyll extract
09/14/2011CN101528745B Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes
09/14/2011CN101268079B Pyridazinone derivatives used for the treatment of pain
09/14/2011CN101253175B Method for producing sulfonyl chloride compound
09/14/2011CN101223171B Pharmacokinetically improved compounds
09/14/2011CN101163696B Histone deacetylase inhibitors
09/13/2011US8017643 Condensed heterocyclic pyrazole derivatives as kinase inhibitors
09/13/2011US8017641 P38 inhibitors and methods of use thereof
09/13/2011US8017624 Fused aminopiperidines as dipeptidyi peptidase-IV inhibitors for the treatment or prevention of diabetes
09/13/2011US8017619 Compositions useful as inhibitors of protein kinases
09/13/2011US8017291 Image-forming material
09/13/2011CA2619077C Methods for the preparation of hcv polymerase inhibitors
09/13/2011CA2552503C Pyrrolopyrimidine and pyrrolotriazine derivatives
09/13/2011CA2486869C Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
09/13/2011CA2454125C Novel materials for selective trapping of carbon monoxide
09/13/2011CA2425268C Pyridinone derivatives for treatment of atherosclerosis
09/13/2011CA2407573C Imidazopyridine derivatives
09/09/2011WO2011109587A1 Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators
09/09/2011WO2011109471A1 Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof
09/09/2011WO2011109470A1 Heteroaryl nitrile compounds useful as inhibitors of cathepsin-s
09/09/2011WO2011108689A1 Pyrazolopyrimidine derivative
09/09/2011WO2011107726A1 Methods and intermediates for the synthesis of 4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazines
09/09/2011WO2011107474A1 Derivatives of aminoindanes, their preparation and their application in therapeutics
09/09/2011WO2011107248A1 NOVEL COMPOUNDS FOR MODULATION OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ GAMMA, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASE
09/09/2011WO2011057145A3 Imidazo[1,2-a] pyridine compounds, synthesis thereof, and methods of using same
09/09/2011WO2011056630A3 Small molecule inhibitors of hepatitis c virus
09/09/2011WO2010123956A3 2,5-disubstituted arylsulfonamide ccr3 antagonists
09/09/2011CA2792102A1 Pyrazolopyrimidine derivative
09/09/2011CA2791715A1 Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators
09/09/2011CA2791431A1 Derivatives of aminoindanes, their preparation and their application in therapeutics
09/09/2011CA2789480A1 Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof
09/08/2011US20110218330 Novel triazolo pyrimidine compounds
09/08/2011US20110218211 Azaindole inhibitors of iap
09/08/2011US20110218210 Compounds for treating abnormal cellular proliferation
09/08/2011US20110218202 Soluble guanylate cyclase activators